Keudell Novo Nordisk A S Transaction History
Keudell
- $372 Million
- Q4 2024
A detailed history of Keudell transactions in Novo Nordisk A S stock. As of the latest transaction made, Keudell holds 8,548 shares of NVO stock, worth $745,129. This represents 0.2% of its overall portfolio holdings.
Number of Shares
8,548
Previous 8,170
4.63%
Holding current value
$745,129
Previous $972,000
24.38%
% of portfolio
0.2%
Previous 0.27%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,867Shares Held
322MCall Options Held
5.49MPut Options Held
7.77M-
Jennison Associates LLC19.9MShares$1.74 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.25 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.25 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.1 Billion0.44% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.06 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $197B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...